HNRNPUL1 p.Gly625Ser

Variant summary

Our verdict is Uncertain significance.
0 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 0 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_SupportingB3_Supporting

The NM_007040.6(HNRNPUL1):c.1873G>A (p.Gly625Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene HNRNPUL1 is a known oncogene (CancerMine: 2 oncogene citations). The variant allele was found at a cumulative frequency of 0.00000349 (AC=5) in the gnomAD database across 1,433,740 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00000134. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000035 ( 0 hom. )

Consequence

HNRNPUL1
NM_007040.6 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.86

Publications

0 publications found
Variant links:
Genes affected
HNRNPUL1 (HGNC:17011): (heterogeneous nuclear ribonucleoprotein U like 1) This gene encodes a nuclear RNA-binding protein of the heterogeneous nuclear ribonucleoprotein (hnRNP) family. This protein binds specifically to adenovirus early-1B-55kDa oncoprotein. It may play an important role in nucleocytoplasmic RNA transport, and its function is modulated by early-1B-55kDa in adenovirus-infected cells. [provided by RefSeq, Mar 2016]
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TGFB1 Gene-Disease associations (from GenCC):
  • Camurati-Engelmann disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Camurati-Engelmann disease type 1
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • inflammatory bowel disease, immunodeficiency, and encephalopathy
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_007040.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 0 points.

O3Absent or very rare in population
Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000001 — very rare (O3 supporting [+1])
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_007040.6. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

HNRNPUL1 NM_007040.6
MANE Select
HGVSc / HGVSpc.1873G>Ap.Gly625Ser
Exon rankExon 12 of 15
missense
Prot: NP_008971.2
HNRNPUL1 NM_001439168.1
HGVSc / HGVSpc.1873G>Ap.Gly625Ser
Exon rankExon 12 of 15
missense
Prot: NP_001426097.1
HNRNPUL1 NM_001439167.1
HGVSc / HGVSpc.1873G>Ap.Gly625Ser
Exon rankExon 12 of 15
missense
Prot: NP_001426096.1UniProt: Q9BUJ2-2

Ensembl Transcripts

HNRNPUL1 ENST00000392006.8
TSL:1MANE Select
HGVSc / HGVSpc.1873G>Ap.Gly625Ser
Exon rankExon 12 of 15
missense
Prot: ENSP00000375863.2UniProt: Q9BUJ2-1
HNRNPUL1 ENST00000602130.5
TSL:1
HGVSc / HGVSpc.1873G>Ap.Gly625Ser
Exon rankExon 12 of 15
missense
Prot: ENSP00000470687.1UniProt: Q9BUJ2-2
HNRNPUL1 ENST00000352456.7
TSL:1
HGVSc / HGVSpc.1573G>Ap.Gly525Ser
Exon rankExon 12 of 15
missense
Prot: ENSP00000340857.3UniProt: A0A0A0MRA5

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
Cov:31
GnomAD2 exomes
AF: 0.00000875
AC:2
AN:228686
GnomAD4 exome
AF: 0.00000349
AC:5
Hom:0
AN:1433740
Cov:31
GnomAD4 genome
Cov:31
TOPMed (Bravo)
AF: 0.00000378
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:15962
Showing 6 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.00 048444 0.0000134 174538
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational Scores

AlphaGenome AVI
Uncertain17
AlphaMissense
Benign0.077
BayesDel_addAF
Benign-0.034T
BayesDel_noAF
Benign-0.26
CADD
Benign22
DANN
Uncertain1.0
DEOGEN2
Benign0.024T
Eigen
Benign-0.43
Eigen_PC
Benign-0.31
FATHMM_MKL
Uncertain0.81D
FuncVEP CTI
Benign0.0013
GPN-Star LLR
N/A-3.2
GPN-Star score
N/A3.2
LIST_S2
Uncertain0.86D
M_CAP
Benign0.065D
MetaRNN
Benign0.16T
MetaSVM
Benign-0.37T
Mutation Taster
N/A91/9polymorphism
MutationAssessor
Benign1.2L
PhyloP100
Benign1.9
popEVE
Benign-3.1
PrimateAI
Benign0.48T
PROVEAN
Benign-1.9N
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A3.2
REVEL
Benign0.14
Sift
Benign0.17T
Sift4G
Uncertain0.019D
Varity_R
N/A0.050
VESM-3B
Benign-6.4
Showing 30 of 30 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.010
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.